Surrey Heartlands

Joint Formulary & PAD

Leuprorelin acetate - Precocious puberty

You are here : Home > Formulary Search > Leuprorelin acetate - Precocious puberty

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Amber
Formulations :
  • Subcutaneous injection (sc)
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
SPC
Restrictions / Comments :

Documentation

Shared Care
Triptorelin for Precocious puberty - Amber Shared Care ASPH - Feb 2011
Shared Care
Triptorelin for precocious puberty - Amber Shared Care RSCH - Feb 2011
Shared Care
Triptorelin for Precocious puberty - Amber Shared Care SASH - Feb 2011
Shared Care
Triptorelin for Precocious Puberty - Amber Shared Care ESHUT - Nov 2013

PAD Profile

ChemicalSubstance :
Leuprorelin acetate
Indication :
Precocious puberty
Group Name :
Keywords :
Brand Names Include :
Prostap
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
4

Other Indications

Below are listed other indications that Leuprorelin acetate is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Precocious puberty.

Committee Recommendations (2)

02 Jul 25 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

Follow link to Shared Care Principles and Communication letters Shared Care principles and Communication letters

14 May 25 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

During the process of reviewing drugs for inclusion on the Surrey Heartlands Joint Formulary, it was noted that Leuprorelin had not been included within the shared care arrangements for treatment of precocious puberty.

Leuprorelin did not have a license for this indication at the point of agreeing shared care for triptorelin. 

Leuprorelin is now licensed for precocious puberty and can be used in accordance with the shared care agreement.

The shared care document will be reviewed and updated.